Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Marshall

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Work (Reading, Mass.)|April 13, 2007
Precarious employment experiences and their health consequences: towards a theoretical frameworkEmile Tompa, Heather Scott-Marshall, Roman Dolinschi, et al.
Clinical Pharmacokinetics|February 21, 2006
Role of mechanistically-based pharmacokinetic/pharmacodynamic models in drug development : a case study of a therapeutic proteinScott Marshall, Fiona Macintyre, Ian James, et al.
Hematological Oncology|March 8, 2008
The therapeutic potential of the proteasome in leukaemiaScott Marshall McCloskey, Mary Frances McMullin, Brian Walker, et al.
Journal of Clinical Pharmacology|June 12, 2019
Population Pharmacokinetics of Pregabalin Extended-Release in Healthy Volunteers and Patients With Postherpetic Neuralgia, Fibromyalgia, and Partial-Onset SeizuresMarci Chew, Guangli Ma, Rujia Xie, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 20, 2023
Prediction of relative change in free nerve growth factor following subcutaneous administration of tanezumab, a novel monoclonal antibody to nerve growth factorSatoshi Shoji, Akiyuki Suzuki, Parya Nouri, et al.
British Journal of Haematology|September 2, 2008
G-CSF increases proteasome activity in myeloid cellsScott Marshall McCloskey, Philip Windrum, Mary Frances McMullin, et al.
Clinical Pharmacology and Therapeutics|September 16, 2020
Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug DevelopmentDaniel Hill-McManus, Scott Marshall, Jing Liu, et al.
Studies in Health Technology and Informatics|September 7, 2011
Towards an interoperable information infrastructure providing decision support for genomic medicineMatthias Samwald, Holger Stenzhorn, Michel Dumontier, et al.
Chinese Medicine|December 21, 2010
Integrating findings of traditional medicine with modern pharmaceutical research: the potential role of linked open dataMatthias Samwald, Michel Dumontier, Jun Zhao, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 18, 2008
The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic dataKarin Tunblad, Lars Lindbom, Lynn McFadyen, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Work (Reading, Mass.)|April 13, 2007
Precarious employment experiences and their health consequences: towards a theoretical frameworkEmile Tompa, Heather Scott-Marshall, Roman Dolinschi, et al.
Clinical Pharmacokinetics|February 21, 2006
Role of mechanistically-based pharmacokinetic/pharmacodynamic models in drug development : a case study of a therapeutic proteinScott Marshall, Fiona Macintyre, Ian James, et al.
Hematological Oncology|March 8, 2008
The therapeutic potential of the proteasome in leukaemiaScott Marshall McCloskey, Mary Frances McMullin, Brian Walker, et al.
Journal of Clinical Pharmacology|June 12, 2019
Population Pharmacokinetics of Pregabalin Extended-Release in Healthy Volunteers and Patients With Postherpetic Neuralgia, Fibromyalgia, and Partial-Onset SeizuresMarci Chew, Guangli Ma, Rujia Xie, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 20, 2023
Prediction of relative change in free nerve growth factor following subcutaneous administration of tanezumab, a novel monoclonal antibody to nerve growth factorSatoshi Shoji, Akiyuki Suzuki, Parya Nouri, et al.
British Journal of Haematology|September 2, 2008
G-CSF increases proteasome activity in myeloid cellsScott Marshall McCloskey, Philip Windrum, Mary Frances McMullin, et al.
Clinical Pharmacology and Therapeutics|September 16, 2020
Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug DevelopmentDaniel Hill-McManus, Scott Marshall, Jing Liu, et al.
Studies in Health Technology and Informatics|September 7, 2011
Towards an interoperable information infrastructure providing decision support for genomic medicineMatthias Samwald, Holger Stenzhorn, Michel Dumontier, et al.
Chinese Medicine|December 21, 2010
Integrating findings of traditional medicine with modern pharmaceutical research: the potential role of linked open dataMatthias Samwald, Michel Dumontier, Jun Zhao, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 18, 2008
The use of clinical irrelevance criteria in covariate model building with application to dofetilide pharmacokinetic dataKarin Tunblad, Lars Lindbom, Lynn McFadyen, et al.
Pageof 9